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WE WILL TRY to show how new insight into the 
mechanism of graft acceptance makes possible the 
reexamination of the UNOS policy of cadaver kidney 
allocation primarily by tissue matching criteria. Because 
matching is only marginally relevant to outcome. the 
present practices are prejudicial to the minority recipients 
of this country without a quantum gain in efficient organ 
use. 
A successful transplant was long envisioned as an alien 
patch in a homogeneous hostile sea. This changed for the 
liver in 1969 when karyotyping studies in human female 
recipients of male hepatic allografts showed that the entire 
macrophage system. including the Kupffer cells. was re-
placed with recipient female cells within 100 days.l.2 This 
graft chimerism was assumed to be a special feature of the 
liver for more than 20 years. The illusion of the liver's 
uniqueness was dispelled in 1991 with the demonstration 
that transplanted intestines in ratsJ and humans4 became 
permanently chimeric within a few weeks; the same find-
ings were soon verified in other transplanted organs. 
Between 1991 and now. it was discovered what hap-
pened to the donor leukocytes replaced in the liver. 
intestinal. and other grafts. A combination of clinical and 
experimental observations (summarized in ref 5) showed 
that these donor cells leave the graft within minutes and 
pass into the lymphoid organs including the thymus. Un-
der effective immunosuppression in rats (and probably 
somewhat later in humans). they disperse ubiquitously 
after 2 to 4 weeks and thereafter can be found in the heart. 
skin. and elsewhere. 
With organs vascularized by surgical anastomosis. the 
primary cell migration is vascular. with prompt secondary 
inclusion of the lymphatic circulation. Multiple lineages of 
chimeric cells home to areas of lymphoid organs where 
syngeneic cells of the same lineages normally traffic.6 For 
example. in the thymus. macrophages and dendritic cells 
show up in the medulla with T and B cells in the follicles. 
At first, the thymic cortex is donor cell free. In the lymph 
nodes. B cells are home to follicles. T cells to the T -lym-
phocyte-rich paracortex. and macrophages and dendritic 
cells to both medulla and paracortex. The spleen traffic 
conforms to the substructure of the periarterial sheath 
anatomy. After the cells break out of the lymphoid organs. 
they spread ubiquitously and. in human cases. can be 
found 20 and 30 years later in the skin. lymph nodes. and 
elsewhere. 
Under immunosuppression. these events apparently 
lead to a body-wide mutual engagement. activation. and 
ultimately clonal "silencing" of both donor and recipient 
immunocytes.5•7 These cell interactions are thought to 
play a crucial role in the "acceptance" of allo- and 
,5 teO 
xenografts under immunosuppression and to participate in 
the first step of the induction of donor specific nonrcactiv-
ity. The nonreactivity which resembles the "infectious" 
tolerance described in a recent Science article by Wald-
manns also develops the other way round. explaining the 
rarity of graft-versus-host disease (GVHD) in human re-
cipients of both intestinal and liver grafts that contain a 
dense migratory leukocyte component. 
Systemic chimerism has been most extensively studied 
after liver transplantation.9 It was demonstrated in all 2S 
liver recipients studied in 1992. 2 to 22 years after liver 
transplantation, either by finding donor cells in peripheral 
tissue with immunostaining by donor-specific HLA anti-
bodies or by identifying donor DNA by polymerase chain 
reaction (peR); and in nine female recipients of male livers 
by the presence of the Y chromosome in these tissues with 
cytostaining or peR technologies. 
Relevant to today's discussion. the same systemic chi-
merism was demonstrated in five patients studied after 
they had borne their continuously well-functioning kidney 
transplants for nearly 30 years posttransplantation. 10 All 
were HLA mismatched and thus could be studied (along 
with their donors) by finding the HLA alleles in peripheral 
tissues with immunostaining or peR. Viable donor cells 
that appeared to be dendritic cells were found in the lymph 
nodes and skin of all of these kidney recipients and then 
confirmed with peR. 
Under the conditions of clinical whole organ transplan-
tation. we have postulated and obtained evidence of cel-
lular interactions (graft-versus-host and host-versus-graft) 
that we have called mutual natural immunosuppression. 
These are envisioned as occurring on a sliding scale in 
which each further level of histoincompatibility provokes 
countervailing increases in the initial immune response. 
This initial response is genetically controlled. However, if 
the acute storm can be weathered long enough to allow a 
rapprochement under the protective umbrella of modem 
day immunosuppression. the anticipated typing effect rap-
idly dwindles. We think that this explains the poor corre-
lation of tissue matching with outcome after all kinds of 
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whole organ cadaver transplantation, short of a perfect 
match.s.7.9 
As to matching, it has been 27 years since the first 
prospective trials of HLA matching in kidney transplanta-
tion were begun by our team at the V niversity of Colorado 
in collaboration with Dr Paul Terasaki of VCLA. II The 
logical assumption was made that this kind of donor-
recipient pairing would be a definitive way of improving 
the results. The anticipated results were obtained with 
perfectly matched siblings, but not with other donor-
recipient pairings. 12 
However, the power of anticipation that the same thing 
would apply in unrelated cases with lesser degrees of 
matching has been so great that it has not been shaken. in 
spite of the fact that thousands of confiicting reports have 
not allowed this question to come to scientific closure. A 
matching effect either has not been found or even in the 
most optimistically presented large collections has been 
confined to a few percentage points mounted on the 
successes without matching that have become greater and 
greater over the years. 
Matching as a guide for organ deployment has been 
thought by many to endow little or no advantage to the 
cadaveric-kidney recipient except when there is a perfect 
match and to have become an instrument of social injus-
tice. specifically affecting the black patient whose chances 
of obtaining a good match and therefore a kidney are 
diminished. 13 •14 Armed with the paradigm shift in under-
standing of matching that derives from the mechanisms we 
have described. the time has come to address this issue 
with a different approach than the usual fiery debate 
between those lined up on one side or the other side of the 
matching issue. 
There is more at stake than matching per se. The 
naturally occurring postoperative cell migration and repop-
ulation responsible for graft acceptance can be augmented 
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perioperatively by infusion of donor bone marrow, blood 
(donor specific transfusion), and presumably other donor 
leukocyte sources including the spleen. This could build up 
the conditions for leukocyte-poor organs (like the kidney 
and heart) to the immunologic advantage enjoyed by the 
tolerogenic liver.S.7.9.IO It is ironic that the present HLA-
dominated VNOS distribution scheme with its quasi-legal 
status, emphasis on matching, and necessity for kidney 
transport is the single greatest logistic impediment to the 
exploitation of this next and much needed phase of devel-
opment. 
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